Phase I GMPs clinical trials - 2017
View: 131
Website http://www.compliance4all.com/control/w_product/~product_id=501228LIVE?channel=mailer&camp=Webinar&A |
Edit Freely
Category Clinical Trials, GMP Requirements, Clinical Studies, paid research studies, paid clinical trials, research studies, medical research studies, phase 1 clinical trials, clinical trial phases, FDA regulations
Deadline: May 15, 2017 | Date: May 16, 2017
Venue/Country: Online, U.S.A
Updated: 2017-03-21 16:24:18 (GMT+9)
Call For Papers - CFP
Overview: Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product.Why should you Attend:Attend this conference so that you may understand differences between GMP requirements for early and later stage clinical development. Explore and discuss ways to develop and implement strategies for early GMPs for phase I clinical studies. Areas Covered in the Session:FDA regulations and Guidance Documents for Phase I clinical trialsKey elements and Best practices of GMP for Phase I clinical trialsIND content and format for CMC informationWho Will Benefit:DirectorsManagers/SupervisorsRegulatory AffairsManufacturingQuality Assurance and Clinical OperationSpeaker Profile:Peggy J. Berry , MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics.Contact Detail:Compliance4All DBA NetZealous,Phone: +1-800-447-9407Email: supportcompliance4All.com
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.